YTE reported $2.69B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 154.84M 15.01M
Agenus AGEN:US USD 208.35M 20.03M
Agios Pharmaceuticals AGIO:US USD 122.45M 33.91M
Alnylam Pharmaceuticals ALNY:US USD 1.07B 497.67M
Amgen AMGN:US USD 9.5B 4.3B
Biocryst Pharmaceuticals BCRX:US USD 461.19M 43.71M
Biogen BIIB:US USD 3.68B 1.03B
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Clovis Oncology CLVS:US USD 58.32M 36.26M
Cti Biopharma CTIC:US USD 32.05M 34.04M
Eli Lilly And LLY:US USD 2.62B 5.5M
Exelixis EXEL:US USD 675.29M 48.29M
Gilead Sciences GILD:US USD 4.7B 40M
Idera Pharmaceuticals IDRA:US USD 26.8M 2.32M
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
IONIS PHARMACEUT IONS:US USD 314.99M 206.92M
Macrogenics MGNX:US USD 83.99M 62.52M
Merk MRK:US USD 11.15B 1.47B
Mirati Therapeutics MRTX:US USD 173.53M 71.97M
Moderna Inc MRNA:US USD 3.03B 154M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Neurocrine Biosciences NBIX:US USD 212.2M 48.9M
Newlink Genetics NLNK:US USD 73.67M 5.84M
Novartis NVS:US USD 8.73B 5.1B
Novartis NOVN:VX USD 8.73B 5.1B
Pfizer PFE:US USD 1.3B 482M
Ptc Therapeutics PTCT:US USD 104.42M 53.73M
Puma Biotechnology PBYI:US USD 77.96M 25.2M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Sarepta Therapeutics SRPT:US USD 1.04B 170.06M
Seattle Genetics SGEN:US USD 362.6M 2.27M
Ultragenyx Pharmaceutical RARE:US USD 391.65M 231.78M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M
YTE INCY:US USD 2.69B 255.24M